Posted: November 15, 2010 1:19 p.m. EST
Summary:
Reuters reports StemCells Inc. filed for Swiss regulatory approval to begin a clinical trial of its nerve stem cells in patients with spinal cord injuries:
LOS ANGELES - StemCells Inc. has filed for Swiss regulatory approval for the first clinical trial of its nerve stem cells in patients with spinal cord injuries as much as a year old, the company said. It expects to enroll about a dozen patients whose injuries are between three and 12 months old.
